Market revenue in 2023 | USD 428.7 million |
Market revenue in 2030 | USD 738.1 million |
Growth rate | 8.1% (CAGR from 2023 to 2030) |
Largest segment | Ultrasound |
Fastest growing segment | PAMG-1 Immunoassay |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Pelvic exam, Ultrasound, Biochemical Markers, Uterine Monitoring, Nitazine Test, Ferning Test, Pooling, PAMG-1 Immunoassay, IGFBP Test, Fetal Fibronectin (fFN) |
Key market players worldwide | Qiagen NV, Hologic Inc, CooperSurgical, Abbott Laboratories, Biosynex, Sera Prognostics, Medix Biochemica, Clinical Innovations, NX Prenatal, IQ Products |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to preterm birth and prom testing market will help companies and investors design strategic landscapes.
Ultrasound was the largest segment with a revenue share of 31.54% in 2023. Horizon Databook has segmented the Europe preterm birth and prom testing market based on pelvic exam, ultrasound, biochemical markers, uterine monitoring, nitazine test, ferning test, pooling, pamg-1 immunoassay, igfbp test, fetal fibronectin (ffn) covering the revenue growth of each sub-segment from 2018 to 2030.
The growth of Europe preterm birth and PROM testing market can be attributed to high awareness regarding maternal health and increased adoption of innovative tests in countries such as Germany, the UK, Italy, and France.
In addition, local presence of key players and continuous R&D initiatives in the area of preterm births and PROM testing are further expected to fuel the market growth in the region. Furthermore, high risk of preterm births and PROM due to high prevalence of alcohol abuse and tobacco smoking in pregnant women in the region is expected to drive the demand for testing solutions.
Horizon Databook provides a detailed overview of continent-level data and insights on the Europe preterm birth and prom testing market , including forecasts for subscribers. This continent databook contains high-level insights into Europe preterm birth and prom testing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account